Obesity and Serum High Sensitivity C-Reactive Protein Levels Among Elderly Turkish Immigrants in the Netherlands with Type 2 Diabetes

[1]  G. Can,et al.  Coronary disease risk prediction algorithm warranting incorporation of C-reactive protein in Turkish adults, manifesting sex difference. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[2]  A. Verhoeff,et al.  Ethnic differences in systemic inflammation: an investigation of C-reactive protein levels among Moroccan, Turkish and Dutch groups in the Netherlands. , 2011, Atherosclerosis.

[3]  Margaret Ashwell,et al.  A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value , 2010, Nutrition Research Reviews.

[4]  L. Hsu,et al.  Insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese. , 2010, Metabolism: clinical and experimental.

[5]  Henry Völzke,et al.  The predictive value of different measures of obesity for incident cardiovascular events and mortality. , 2010, The Journal of clinical endocrinology and metabolism.

[6]  G. Zarini,et al.  Waist Circumference and BMI in Relation to Serum High Sensitivity C-Reactive Protein (hs-CRP) in Cuban Americans With and Without Type 2 Diabetes , 2010, International journal of environmental research and public health.

[7]  M. Gönen,et al.  Optimal waist:height ratio cut-off point for cardiometabolic risk factors in Turkish adults , 2009, Public Health Nutrition.

[8]  J. Saltevo,et al.  Gender differences in adiponectin and low-grade inflammation among individuals with normal glucose tolerance, prediabetes, and type 2 diabetes. , 2009, Gender medicine.

[9]  M. Gönen,et al.  Anthropometric indices and their relationship with cardiometabolic risk factors in a sample of Turkish adults , 2009, Public Health Nutrition.

[10]  N. Abdella,et al.  Which Obesity Index Best Explains the Link between Adipokines, Coronary Heart Disease Risk and Metabolic Abnormalities in Type 2 Diabetes Mellitus? , 2009, Medical Principles and Practice.

[11]  A. Malarcher,et al.  Cigarette Smoking Among Adults in the United States , 2008 .

[12]  I. Parra-Rojas,et al.  Cardiovascular risk evaluated by C-reactive protein levels in diabetic and obese Mexican subjects. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[13]  G. Can,et al.  Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. , 2008, Metabolism: clinical and experimental.

[14]  G. Treviño.  Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C Measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation , 2007, Diabetes Care.

[15]  J. Pogue,et al.  Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. , 2007, European heart journal.

[16]  G. Can,et al.  Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. , 2007, Atherosclerosis.

[17]  Winfried März,et al.  Accuracy of anthropometric indicators of obesity to predict cardiovascular risk. , 2007, The Journal of clinical endocrinology and metabolism.

[18]  N. Luciani,et al.  The Inflammatory C-Reactive Protein is Increased in Both Liver and Adipose Tissue in Severely Obese Patients Independently from Metabolic Syndrome, Type 2 Diabetes, and NASH , 2006, The American Journal of Gastroenterology.

[19]  E. Rimm,et al.  Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. , 2006, Atherosclerosis.

[20]  K. Prasad.  C-reactive protein (CRP)-lowering agents. , 2006, Cardiovascular drug reviews.

[21]  M. Laakso,et al.  High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study. , 2006, Diabetes care.

[22]  L. Chambless,et al.  Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women , 2005, Thrombosis and Haemostasis.

[23]  A. Hoes,et al.  Prevalence of type 2 diabetes mellitus, other cardiovascular risk factors, and cardiovascular disease in Turkish and Moroccan immigrants in North West Europe: a systematic review. , 2004, Preventive medicine.

[24]  A. Häkkinen,et al.  Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk , 2004, Diabetologia.

[25]  J. Pickup.  Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. , 2004, Diabetes care.

[26]  J. Boeke,et al.  Hoge prevalentie van diabetes mellitus type 2 bij Turken en Marokkanen , 2003 .

[27]  M. Visser,et al.  Prospective relation of C-reactive protein with type 2 diabetes: response to Han et al. , 2003, Diabetes care.

[28]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[29]  B. Zinman,et al.  Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree , 2003, International Journal of Obesity.

[30]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[31]  Cze,et al.  Hart- en vaatziekten bij allochtonen in Nederland. Een cijfermatige verkenning naar leefstijl- en risicofactoren, ziekte en sterfte , 2002 .

[32]  A. Onat,et al.  C-reactive protein and coronary heart disease in western Turkey. , 2001, The American journal of cardiology.

[33]  N. Shaik,et al.  Gender-specific associations between insulin resistance, hypertension, and markers of inflammation among adult Saudis with and without diabetes mellitus type 2. , 2010, Advances in medical sciences.

[34]  G. Zarini,et al.  Metabolic syndrome and high-sensitivity C-reactive protein in Cubans. , 2009, Ethnicity & disease.

[35]  P. Suriyawongpaisal,et al.  Comparative study of two automated high-sensitivity C-reactive protein methods in a large population. , 2005, Clinical biochemistry.

[36]  A. Hoes,et al.  Cardiovascular risk factors in Turkish immigrants with type 2 diabetes mellitus: Comparison with Dutch patients , 2004, European Journal of Epidemiology.

[37]  A. Trosclair,et al.  Cigarette smoking among adults--United States, 2000. , 2002, MMWR. Morbidity and mortality weekly report.

[38]  D. Jacobs,et al.  Changes in measurements of body fat distribution accompanying weight change. , 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[39]  P B Herdson,et al.  Ethnic differences. , 1990, The New Zealand medical journal.